CIAC-001

N/A

Report date: 2023/08/04 13:39:03
NME

Base Information

Drug NameCIAC-001
Drug Alias NameCIAC001CIAC-001
ClassificationSmall molecules
Mechanisms of ActionPyruvate kinase isozymes M1/M2 activators
TargetsPyruvate kinase isozymes M1/M2
Therapy Area/IndicationsMorphine Dependence
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesUniversity Of Science And Technology Of ChinaChangchun Institute Of Applied Chemistry Chinese Academy Of Sciences
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Science And Technology Of ChinaChangchun Institute Of Applied Chemistry Chinese Academy Of Sciences
Inactive CompaniesN/A
Active IndicationsMorphine Dependence
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A